Patents Assigned to Defyrus, Inc.
  • Publication number: 20130315952
    Abstract: The invention provides compositions and methods for the prophylaxis or treatment of diseases or disorders in a subject (e.g., a mammal, such as a human) including, e.g., diseases or disorders caused by biological agents, autoimmune diseases, and cancer. The compositions include a delivery vector (e.g., a viral vector, such as an Ad5 vector) encoding an interferon (e.g., IFN-?), and are provided to the subject by, e.g., intranasal or pulmonary administration.
    Type: Application
    Filed: November 13, 2012
    Publication date: November 28, 2013
    Applicant: Defyrus, Inc.
    Inventors: Jeffrey D. Turner, Jane E. Ennis
  • Patent number: 8309531
    Abstract: The invention provides compositions and methods for the prophylaxis or treatment of diseases or disorders in a subject (e.g., a mammal, such as a human) including, e.g., diseases or disorders caused by biological agents, autoimmune diseases, and cancer. The compositions include a delivery vector (e.g., a viral vector, such as an Ad5 vector) encoding an interferon (e.g., IFN-?), and are provided to the subject by, e.g., intranasal or pulmonary administration.
    Type: Grant
    Filed: June 9, 2010
    Date of Patent: November 13, 2012
    Assignee: Defyrus, Inc.
    Inventors: Jeffrey D. Turner, Jane E. Ennis